Active Pharmaceutical Ingredients

IDRA21

7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide

CAS: 22503-72-6

Molecular formula: C8H9ClN2O2S

Molecular weight: 232.69

Custom Service Available

IDRA-21 is an ampakine substance and an experimental product. It is a drug that can positively regulate AMPA receptors. IDRA 21 is expected to be used in the development of drug components for the treatment of cognitive/memory disorders, including age-related diseases.

IDRA-21 has a cognitive enhancing effect. For example, improving memory and learning abilities. It enhances neural transmission by increasing the activity of AMPA receptors, which are involved in learning and memory functions.
Compared with Ampagliflozin, IDRA-21 is more effective, mainly reflected in its long half-life and more persistent activity.

Research stage: IDRA-21 has not yet been approved for medical use.
IDRA-21 is an investigational puzzle drug called Ampagliflozin, which enhances AMPA receptor activity and has shown potential for cognitive enhancement in animal studies. However, it has not yet been approved and has not been fully studied in humans.